Clinical Trials Directory

Trials / Completed

CompletedNCT04986384

Effect of a Topical Spray on Itch Relief in Moderate-to-severe Childhood Eczema

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Prof. HON Kam Lun Ellis · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pruritus is defined as an unpleasant sensation of the skin that provoke the desire to scratch or rub. Its presence is an essential diagnostic feature. According to some European studies, 91% of patients with Atopic Dermatitis report suffering from pruritus at least once daily. And 58.1% of them experience chronic pruritus, leading to great deterioration in quality of life. Various internal and external factors may trigger pruritus. Mediators secretion such as keratinocyte-derived Thymic Stromal Lymphopoietin (TSLP) and Nerve Growth Factor (NGF) could activate nerve fibres which will eventually transmit signals to the brain causing the sensation of itching. Although being one of the major annoying symptoms faced by patients with Atopic Dermatitis, effective anti-itching treatments are not available. There is no consistent evidence that topical antihistamines can relief itch. Recently, a new spray named Atoderm 'SOS' is developed. The skin relief technology (by ambora extract and Epigallocatechin gallate (EGCG), associated to enoxolone) claimed to inhibit the release TSLP and NGF which eventually could reduce nerve signals to the brain for itchy feelings. Therefore, our group would like to test the efficacy of this proprietary anti-itch product with our paediatric patients using a wait-list approach as a control. It is aimed to demonstrate that the using the Atoderm 'SOS' spray topically whenever necessary can reduce the unpleasant itchy Atopic Dermatitis's symptom, improve quality of life, as well as to reduce the need for topical treatment.

Conditions

Interventions

TypeNameDescription
DRUGAtoderm SOS spray Aerosol 200mlA bottle of 200ml topical spray was used on the eczematous skin lesions for itch relief.

Timeline

Start date
2019-01-24
Primary completion
2021-04-07
Completion
2021-04-07
First posted
2021-08-02
Last updated
2021-08-02

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT04986384. Inclusion in this directory is not an endorsement.